Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Amicus Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- −7 vs. Q1 2023
- Shares held
- 307.3M
- +9.58M (+3.2%) vs. Q1 2023
- Total value
- $3.86B
- +$557.0M (+16.9%) vs. Q1 2023
- New holders
- 25
- 82 more added
- Sold out
- 32
- 73 more reduced
3 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $11.5K |
| Q1 2026 | 298 | $4.81B |
| Q4 2025 | 332 | $4.57B |
| Q3 2025 | 287 | $2.46B |
| Q2 2025 | 272 | $1.83B |
| Q1 2025 | 286 | $2.55B |
| Q4 2024 | 290 | $2.88B |
| Q3 2024 | 293 | $3.31B |
| Q2 2024 | 259 | $3.13B |
| Q1 2024 | 254 | $3.79B |
| Q4 2023 | 229 | $4.53B |
| Q3 2023 | 229 | $3.63B |
| Q2 2023 | 216 | $3.86B |
| Q1 2023 | 226 | $3.30B |
| Q4 2022 | 230 | $3.57B |
| Q3 2022 | 222 | $3.05B |
| Q2 2022 | 213 | $3.28B |
| Q1 2022 | 216 | $2.87B |
| Q4 2021 | 224 | $3.48B |
| Q3 2021 | 238 | $2.80B |
| Q2 2021 | 235 | $2.67B |
| Q1 2021 | 259 | $2.74B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 6,921,981 | $86.9M | 0.10% | −249,054−3.5% | Reduced |
| Point72 Asset Management, L.P. | 7,000,900 | $87.9M | 0.30% | +4,751,772+211.3% | Added |
| Wellington Management Group LLP | 7,820,296 | $98.2M | 0.02% | +305,255+4.1% | Added |
| Pictet Asset Management SA | 9,442,588 | $118.6M | 0.14% | −542,313−5.4% | Reduced |
| Palo Alto Investors LP | 10,524,022 | $132.2M | 10.68% | 00.0% | Unchanged |
| State Street Corp | 11,179,242 | $140.4M | 0.01% | +48,357+0.4% | Added |
| Morgan Stanley | 13,060,808 | $164.0M | 0.02% | −3,440,101−20.8% | Reduced |
| JPMorgan Chase & Co | 13,442,391 | $168.8M | 0.02% | −291,094−2.1% | Reduced |
| Janus Henderson Group PLC | 14,923,588 | $187.4M | 0.12% | +1,313,153+9.6% | Added |
| Redmile Group, LLC | 19,566,961 | $245.8M | 9.43% | +1,220,100+6.7% | Added |
| BlackRock Inc. | 20,898,593 | $262.5M | 0.01% | +1,160,568+5.9% | Added |
| Vanguard Group Inc | 27,024,417 | $339.4M | 0.01% | +162,472+0.6% | Added |
| Avoro Capital Advisors LLC | 27,400,000 | $344.1M | 4.67% | +100,000+0.4% | Added |
| Perceptive Advisors LLC | 27,662,917 | $347.4M | 10.09% | 00.0% | Unchanged |
| Valley National Advisers Inc | 20 | – | – | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 1,627 | – | – | +1,627 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −389,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −387,654−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −330,425−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −267,931−100.0% | Sold out |
| Lombard Odier Asset Management (Switzerland) SA | 0 | $0 | 0.00% | −261,592−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −258,288−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −204,695−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −204,119−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −133,697−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −94,890−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −92,256−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −134,745−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −68,113−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −47,072−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −39,600−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −36,400−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −32,307−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −26,859−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −23,030−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −21,401−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −14,350−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −13,122−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,729−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −11,913−100.0% | Sold out |
| Systematic Financial Management LP | 0 | $0 | 0.00% | −11,626−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −10,337−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −9,172−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −538−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −356−100.0% | Sold out |
| Ten Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Zebra Capital Management LLC | – | – | – | – | Not filed |
| Pathway Financial Advisers, LLC | – | – | – | – | Not filed |
| Harvest Group Wealth Management, LLC | – | – | – | – | Not filed |